首页> 美国卫生研究院文献>Frontiers in Medicine >Bleomycin Revisited: A Direct Comparison of the Intratracheal Micro-Spraying and the Oropharyngeal Aspiration Routes of Bleomycin Administration in Mice
【2h】

Bleomycin Revisited: A Direct Comparison of the Intratracheal Micro-Spraying and the Oropharyngeal Aspiration Routes of Bleomycin Administration in Mice

机译:再谈博莱霉素:博莱霉素对小鼠的气管内微喷涂和口咽抽吸途径的直接比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Idiopathic Pulmonary Fibrosis (IPF) is a fatal disease characterized by exuberant deposition of extracellular matrix components, deterioration of lung architecture and impairment of lung functions. Its etiopathogenesis remains incompletely understood, as reflected in the lack of an appropriate therapy. Modeling the human disease in mice via the administration of bleomycin (BLM), despite the inherent limitations, has provided valuable insights into the underlying pathogenetic mechanisms, and has been instrumental for the development and validation of new pharmacologic interventions. Here we have directly compared the, most widely used, intratracheal (IT) route of administration with oropharyngeal aspiration (OA). Our results suggest that the OA route of BLM-administration can be used as a safe and effective alternative, minimizing peri-operative and experimental mortality, while preserving a solid fibrotic profile, as assessed with a plethora of standardized readout assays.
机译:特发性肺纤维化(IPF)是一种致命疾病,其特征是细胞外基质成分大量沉积,肺结构恶化和肺功能受损。缺乏适当的治疗反映了其病因尚未完全阐明。尽管有固有的局限性,但通过博莱霉素(BLM)的给药对小鼠的人类疾病进行建模,已为潜在的致病机制提供了宝贵的见识,并为开发和验证新的药理学干预手段提供了帮助。在这里,我们直接比较了最广泛使用的气管内(IT)给药途径与口咽抽吸(OA)的比较。我们的研究结果表明,BLM的OA途径可作为一种安全有效的替代方法,可最大限度地降低围手术期和实验性死亡率,同时保留坚实的纤维化特性,这是通过大量标准化读出法评估得出的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号